Pelthos Therapeutics Inc.
Pelthos Therapeutics Inc. (PTHS) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · PTHS · as of Jun 9, 2026
Activity summary
Buy transactions
1
P-Purchase only
Sell transactions
13
12 Months
Buy/Sell ratio
0.08
Buy/Sell (by trades)
Overall sentiment
Pelthos Therapeutics Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
PTHS insider buying and selling by quarter
PTHS insider selling · PTHS insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · PTHS ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
PTHS executive sell shares · PTHS board member insider trading · PTHS insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 22, 2026 | Francis Knuettel II CFO, Treas & Secty | Other | 13,947 | — | Form 4 |
| May 22, 2026 | Francis Knuettel II CFO, Treas & Secty | Sale | 1,500 | $40K | Form 4 |
| May 14, 2026 | Friedberg Ezra M Director | Other | 144 | $4K | Form 4 |
| Apr 2, 2026 | Malamut Richard Director | Sale | 310 | $6K | Form 4 |
| Apr 2, 2026 | Malamut Richard Director | Sale | 280 | $6K | Form 4 |
| Apr 2, 2026 | Friedberg Ezra M Director | Sale | 293 | $6K | Form 4 |
| Apr 2, 2026 | Friedberg Ezra M Director | Sale | 265 | $6K | Form 4 |
| Apr 2, 2026 | Pauls Matthew Director | Sale | 415 | $9K | Form 4 |
| Apr 2, 2026 | Pauls Matthew Director | Sale | 371 | $8K | Form 4 |
| Apr 2, 2026 | Greenleaf Peter Director | Sale | 420 | $9K | Form 4 |
| Apr 2, 2026 | Greenleaf Peter Director | Sale | 377 | $8K | Form 4 |
| Dec 23, 2025 | Einhorn Andrew J. Director | Award | 12,000 | $1 | Form 4 |
| Oct 2, 2025 | Pauls Matthew Director | Option | 2,123 | — | Form 4 |
| Jul 2, 2025 | Pauls Matthew Director | Option | 8,493 | — | Form 4 |
| Dec 10, 2025 | Pauls Matthew Director | Gift | 9,542 | — | Form 4 |
| Nov 25, 2025 | Friedberg Ezra M Director | Sale | 5,999 | $168K | Form 4 |
| Nov 25, 2025 | Friedberg Ezra M Director | Sale | 2,000 | $56K | Form 4 |
| Nov 25, 2025 | Friedberg Ezra M Director | Sale | 1 | $29 | Form 4 |
| Nov 25, 2025 | Friedberg Ezra M Director | Sale | 2,000 | $56K | Form 4 |
| Jul 1, 2025 | Friedberg Ezra M Director | Other | 40,000 | $400K | Form 4 |
| Jul 1, 2025 | Francis Knuettel II CFO | Other | 10,000 | $100K | Form 4 |
| Jul 1, 2025 | Davis Todd C Director | Other | 1,500,000 | $15.00M⚡ | Form 4 |
| Jul 1, 2025 | LIGAND PHARMACEUTICALS INC 10 percent owner | Other | 1,500,000 | $15.00M⚡ | Form 4 |
Francis Knuettel II
CFO, Treas & Secty
Date
May 22
Shares
1,500
Price
$26.84
Value
$40K
LIGAND PHARMACEUTICALS INC
10 percent owner
Date
Jul 1
Shares
1,500,000
Price
$10.00
Value
$15.00M ⚡
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About PTHS insider trading
PTHS insider trades
Pelthos Therapeutics Inc. (PTHS) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Friedberg Ezra M (Director), Pauls Matthew (Director), Francis Knuettel II (CFO, Treas & Secty). Over the past 12 months, 5 insiders have filed transactions with the SEC. PTHS insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Pelthos Therapeutics Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
PTHS insider trading · 5 questionsThe insiders of Pelthos Therapeutics Inc. (PTHS) include executives and directors such as Friedberg Ezra M (Director), Pauls Matthew (Director), Francis Knuettel II (CFO, Treas & Secty), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026